Yidu Tech wins RMB7.39 million contract to build intelligent clinical research platform for Tianjin Medical University Cancer Institute

Bulletin Express05-21

On 21 May 2026, Yidu Tech Inc. (Yidu Tech) announced that its affiliate, Yidu Cloud (Beijing) Technology Co., Ltd., secured the tender to construct an intelligent clinical research integrated platform for Tianjin Medical University Cancer Institute and Hospital. The project is valued at approximately RMB 7.39 million.

According to the announcement, the platform will embed Yidu Tech’s proprietary artificial-intelligence capabilities designed to mirror physicians’ clinical decision-making and model real-world disease progression. The company expects the system to support more precise, efficient diagnoses and treatments while enhancing research efficiency for the hospital.

Yidu Tech positions the win as further evidence of its role in advancing intelligent healthcare solutions across China’s medical ecosystem, which spans healthcare services, pharmaceutical development, insurance and patient care.

The board of Yidu Tech is chaired by Executive Director Ms. Gong Yingying. The announcement did not disclose additional financial metrics or implementation timelines for the project.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1184245010?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-21 12:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1184245010","market":"hk","top_or_hot":-1,"title":"Yidu Tech wins RMB7.39 million contract to build intelligent clinical research platform for Tianjin Medical University Cancer Institute","media":"Bulletin Express","content":"<p>On 21 May 2026, Yidu Tech Inc. (Yidu Tech) announced that its affiliate, Yidu Cloud (Beijing) Technology Co., Ltd., secured the tender to construct an intelligent clinical research integrated platform for Tianjin Medical University Cancer Institute and Hospital. The project is valued at approximately RMB 7.39 million.</p>\n<p>According to the announcement, the platform will embed Yidu Tech’s proprietary artificial-intelligence capabilities designed to mirror physicians’ clinical decision-making and model real-world disease progression. The company expects the system to support more precise, efficient diagnoses and treatments while enhancing research efficiency for the hospital.</p>\n<p>Yidu Tech positions the win as further evidence of its role in advancing intelligent healthcare solutions across China’s medical ecosystem, which spans healthcare services, pharmaceutical development, insurance and patient care.</p>\n<p>The board of Yidu Tech is chaired by Executive Director Ms. Gong Yingying. The announcement did not disclose additional financial metrics or implementation timelines for the project.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Yidu Tech wins RMB7.39 million contract to build intelligent clinical research platform for Tianjin Medical University Cancer Institute</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nYidu Tech wins RMB7.39 million contract to build intelligent clinical research platform for Tianjin Medical University Cancer Institute\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-05-21 12:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>On 21 May 2026, Yidu Tech Inc. (Yidu Tech) announced that its affiliate, Yidu Cloud (Beijing) Technology Co., Ltd., secured the tender to construct an intelligent clinical research integrated platform for Tianjin Medical University Cancer Institute and Hospital. The project is valued at approximately RMB 7.39 million.</p>\n<p>According to the announcement, the platform will embed Yidu Tech’s proprietary artificial-intelligence capabilities designed to mirror physicians’ clinical decision-making and model real-world disease progression. The company expects the system to support more precise, efficient diagnoses and treatments while enhancing research efficiency for the hospital.</p>\n<p>Yidu Tech positions the win as further evidence of its role in advancing intelligent healthcare solutions across China’s medical ecosystem, which spans healthcare services, pharmaceutical development, insurance and patient care.</p>\n<p>The board of Yidu Tech is chaired by Executive Director Ms. Gong Yingying. The announcement did not disclose additional financial metrics or implementation timelines for the project.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02158","symbol_name":"医渡科技","start_time":0,"source_url":"","article_id":"1184245010","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1184245010","pubTimestamp":1779338562,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"On 21 May 2026, Yidu Tech Inc. (Yidu Tech) announced that its affiliate, Yidu Cloud (Beijing) Technology Co., Ltd., secured the tender to construct an intelligent clinical research integrated...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02158":"医渡科技"},"translate_title":"医渡科技获739万元合同为天津医科大学肿瘤研究所搭建智能临床研究平台","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02158":1},"content_text":"On 21 May 2026, Yidu Tech Inc. (Yidu Tech) announced that its affiliate, Yidu Cloud (Beijing) Technology Co., Ltd., secured the tender to construct an intelligent clinical research integrated platform for Tianjin Medical University Cancer Institute and Hospital. The project is valued at approximately RMB 7.39 million.\nAccording to the announcement, the platform will embed Yidu Tech’s proprietary artificial-intelligence capabilities designed to mirror physicians’ clinical decision-making and model real-world disease progression. The company expects the system to support more precise, efficient diagnoses and treatments while enhancing research efficiency for the hospital.\nYidu Tech positions the win as further evidence of its role in advancing intelligent healthcare solutions across China’s medical ecosystem, which spans healthcare services, pharmaceutical development, insurance and patient care.\nThe board of Yidu Tech is chaired by Executive Director Ms. Gong Yingying. The announcement did not disclose additional financial metrics or implementation timelines for the project.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.3","shortVersion":"4.42.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1184245010","isCrawlerRequest":true}